■新生儿高胆红素血症的神经损害包括听力丧失和脑病。当前的研究使用“脑干诱发反应测听法(BERA)”测试来筛查和评估从高胆红素血症中康复的新生儿的听力损失。
■在三级护理中心进行了横断面比较研究。包括50例新生儿,其中25例是健康的,25例接受胆红素升高的治疗。在BERA测试之前,受试者的耳朵检查是否有任何阻塞。按照描述的常规实验室程序,BERA的录音是在新生儿自己睡着后进行的。使用方差分析比较收集的数据的显著性,保持P<0.05为显著。
■与对照组相比,很大比例的新生儿有延迟的BERA波潜伏期(I-R=80,L=84;III-R=76,L=84;V-R=84,L=88百分比潜伏期).健康新生儿出现潜伏期的受试者百分比小于病例组(I-R=8,L=24;III-R=8,L=8;V-R=4,L=12百分比潜伏期)。每组中相当数量的婴儿具有较长的峰间潜伏期。病例组中的受试者显示,根据WHO等级的阈值听力为轻度(R=32,L=36)和中度(R=32,L=28)。
■血清胆红素升高可能会损害听力。在高胆红素血症得到完全治疗后,BERA甚至可以检测到最轻微的听力损伤。因此,BERA是一种用于快速识别新生儿听力障碍的有用技术。早期治疗有助于预后,使神经感觉系统完全成熟,病人可以过上高质量的生活。
UNASSIGNED: Neurological harm from neonatal hyperbilirubinemia includes loss of hearing and encephalopathy. The current research used the \"Brainstem Evoked Response Audiometry (
BERA)\" test to screen for as well as assess hearing loss in newborns who had recovered from hyperbilirubinemia.
UNASSIGNED: A cross-sectional comparative investigation was conducted at a tertiary care center. Fifty neonates were included out of which 25 were healthy and 25 received treatment for the increased bilirubin. Prior to
BERA testing, the subjects\' ears were examined for any obstruction. Following a conventional lab procedure described, the
BERA recordings were carried out after the neonate fell asleep on its own. The data collected were compared for the significance using the ANOVA, keeping P < 0.05 as significant.
UNASSIGNED: In comparison to the controls, a large proportion of neonates in cases had
BERA wave latencies that were delayed (I-R = 80, L = 84; III- R = 76, L = 84; V- R = 84, L = 88 percentages latencies). The percentage of subjects in whom the latencies was noted for the healthy neonates was lesser than the case group (I-R = 8, L = 24; III- R = 8, L = 8; V- R = 4, L = 12 percentages latencies). Comparable numbers of infants in each group had inter-peak latencies that were lengthy. Subjects in the case group showed that the threshold hearing as per the WHO grade was mild (R = 32, L = 36) and moderate (R = 32, L = 28).
UNASSIGNED: Elevated serum bilirubin may cause damage to hearing capability. After hyperbilirubinemia has been completely treated, BERA can detect even the slightest degree of hearing damage.
BERA is therefore a useful technique for the quick recognition of hearing impairment in newborns. Early treatment helps in the prognosis so that the neurosensory systems can fully mature, and the patient can lead a quality life.